| __timestamp | Alkermes plc | Viking Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7753000 | 22223073 |
| Thursday, January 1, 2015 | 4019000 | 6966842 |
| Friday, January 1, 2016 | 2301000 | 9000499 |
| Sunday, January 1, 2017 | 7232000 | 13741186 |
| Monday, January 1, 2018 | 68895000 | 19040000 |
| Tuesday, January 1, 2019 | 52816000 | 23559000 |
| Wednesday, January 1, 2020 | 1946000 | 31931000 |
| Friday, January 1, 2021 | 1020000 | 44981000 |
| Saturday, January 1, 2022 | 393842000 | 54234000 |
| Sunday, January 1, 2023 | 270806000 | 63806000 |
| Monday, January 1, 2024 | 245326000 |
In pursuit of knowledge
In the competitive landscape of pharmaceutical innovation, research and development (R&D) spending is a critical indicator of a company's commitment to future growth. Over the past decade, Alkermes plc and Viking Therapeutics, Inc. have shown contrasting trends in their R&D investments. From 2014 to 2023, Alkermes plc's R&D expenses surged by over 3,400%, peaking in 2022 with a remarkable 394 million USD. In contrast, Viking Therapeutics, Inc. demonstrated a steady increase, with a 187% rise, reaching approximately 64 million USD in 2023. This divergence highlights Alkermes' aggressive push in recent years, while Viking maintains a consistent growth trajectory. Such insights into R&D spending can provide investors and industry analysts with valuable foresight into each company's strategic priorities and potential for innovation.
Research and Development: Comparing Key Metrics for AbbVie Inc. and Alkermes plc
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Research and Development Expenses Breakdown: Vertex Pharmaceuticals Incorporated vs Viking Therapeutics, Inc.
R&D Spending Showdown: United Therapeutics Corporation vs Alkermes plc
Research and Development Investment: Pharming Group N.V. vs Alkermes plc
Research and Development Investment: Corcept Therapeutics Incorporated vs Alkermes plc
Research and Development Investment: Alkermes plc vs MiMedx Group, Inc.
Viking Therapeutics, Inc. vs Amicus Therapeutics, Inc.: Strategic Focus on R&D Spending
R&D Spending Showdown: Viking Therapeutics, Inc. vs Bausch Health Companies Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Viking Therapeutics, Inc. and Novavax, Inc.
Viking Therapeutics, Inc. or Evotec SE: Who Invests More in Innovation?